An interaction between human papillomavirus 16 E2 and TopBP1 is required for optimum viral DNA replication and episomal genome establishment

Journal of Virology

Volumn 86, Issue 23, 2012, Pages 12806-12815

  Donaldson, Mary M ^a   Mackintosh, Lorna J ^a   Bodily, Jason M ^b,c   Dornan, Edward S ^a   Laimins, Laimonis A ^b   Morgan, Iain M ^a  

^a MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

^b NORTHWESTERN UNIVERSITY   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; PROTEIN E2; TOPBP1 PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; DNA REPLICATION; EPISOME; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TRANSCRIPTION INITIATION; TRANSCRIPTION TERMINATION; VIRUS GENOME; VIRUS MUTANT;

BLOTTING, SOUTHERN; BLOTTING, WESTERN; CARRIER PROTEINS; DENSITOMETRY; DIMERIZATION; DNA PRIMERS; DNA REPLICATION; DNA-BINDING PROTEINS; HEK293 CELLS; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOPRECIPITATION; MUTAGENESIS, SITE-DIRECTED; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; PLASMIDS; REPLICATION ORIGIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16; MAMMALIA;

EID: 84869226861     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01002-12     Document Type: Article

References (69)

1. Abbate EA, Berger JM, Botchan MR. 2004. The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2. Genes Dev. 18, 1981-1996.
2. Abbate EA, Voitenleitner C, Botchan MR. 2006. Structure of the papillomavirus DNA-tethering complex E2, Brd4 and a peptide that ablates HPV chromosomal association. Mol. Cell 24, 877-889.
3. Abroi A, Ilves I, Kivi S, Ustav M. 2004. Analysis of chromatin attachment and partitioning functions of bovine papillomavirus type 1 E2 protein. J. Virol. 78, 2100-2113.
4. Antson AA, et al. 2000. Structure of the intact transactivation domain of the human papillomavirus E2 protein. Nature 403, 805-809.
5. Bang SW, et al. 2011. Human TopBP1 localization to the mitotic centrosome mediates mitotic progression. Exp. Cell Res. 317, 994-1004.
6. Bastien N, McBride AA. 2000. Interaction of the papillomavirus E2 protein with mitotic chromosomes. Virology 270, 124-134.
7. Baxter MK, McBride AA. 2005. An acidic amphipathic helix in the bovine papillomavirus E2 protein is critical for DNA replication and interaction with the E1 protein. Virology 332, 78-88.
8. Bechtold V, Beard P, Raj K. 2003. Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA. J. Virol. 77, 2021-2028.
9. Benson JD, Howley PM. 1995. Amino-terminal domains of the bovine papillomavirus type 1 E1 and E2 proteins participate in complex formation. J. Virol. 69, 4364-4372.
10. Bernard BA, et al. 1989. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. J. Virol. 63, 4317-4324.
11. Bodily JM, Mehta KP, Cruz L, Meyers C, Laimins LA. 2011. The E7 open reading frame acts in cis and in trans to mediate differentiation-dependent activities in the human papillomavirus type 16 life cycle. J. Virol. 85, 8852-8862.
12. Bodily JM, Meyers C. 2005. Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter. J. Virol. 79, 3309-3321.
13. Boner W, Morgan IM. 2002. Novel cellular interacting partners of the human papillomavirus 16 transcription/replication factor E2. Virus Res. 90, 113-118.
14. Boner W, et al. 2002. A Functional interaction between the human papillomavirus 16 transcription/replication factor E2 and the DNA damage response protein TopBP1. J. Biol. Chem. 277, 22297-22303.
15. Bouvard V, Storey A, Pim D, Banks L. 1994. Characterization of the human papillomavirus E2 protein, evidence of transactivation and transrepression in cervical keratinocytes. EMBO J. 13, 5451-5459.
16. Cha S, Seo T. 2011. hSNF5 is required for human papillomavirus E2-driven transcriptional activation and DNA replication. Intervirology 54, 66-77.
17. Donaldson MM, Boner W, Morgan IM. 2007. TopBP1 regulates human papillomavirus type 16 E2 interaction with chromatin. J. Virol. 81, 4338-4342.
18. Feeney KM, Saade A, Okrasa K, Parish JL. 2011. In vivo analysis of the cell cycle dependent association of the bovine papillomavirus E2 protein and ChlR1. Virology 414, 1-9.
19. Germann SM, et al. 2011. Dpb11/TopBP1 plays distinct roles in DNA replication, checkpoint response and homologous recombination. DNA Repair (Amst.) 10, 210-224.
20. Herold S, et al. 2008. Miz1 and HectH9 regulate the stability of the checkpoint protein, TopBP1. EMBO J. 27, 2851-2861.
21. Hibma MH, Raj K, Ely SJ, Stanley M, Crawford L. 1995. The interaction between human papillomavirus type 16 E1 and E2 proteins is blocked by an antibody to the N-terminal region of E2. Eur. J. Biochem. 229, 517-525.
22. Im JS, et al. 2009. Assembly of the Cdc45-Mcm2-7-GINS complex in human cells requires the Ctf4/And-1, RecQL4, and Mcm10 proteins. Proc. Natl. Acad. Sci. U. S. A. 106, 15628-15632.
23. Jeon Y, et al. 2007. Human TopBP1 participates in cyclin E/CDK2 activation and preinitiation complex assembly during G1/S transition. J. Biol. Chem. 282, 14882-14890.
24. Kim JE, McAvoy SA, Smith DI, Chen J. 2005. Human TopBP1 ensures genome integrity during normal S phase. Mol. Cell. Biol. 25, 10907-10915.
25. King LE, Dornan ES, Donaldson MM, Morgan IM. 2011. Human papillomavirus 16 E2 stability and transcriptional activation is enhanced by E1 via a direct protein-protein interaction. Virology 414, 26-33.
26. Kumagai A, Lee J, Yoo HY, Dunphy WG. 2006. TopBP1 activates the ATR-ATRIP complex. Cell 124, 943-955.
27. Kumagai A, Shevchenko A, Dunphy WG. 2011. Direct regulation of Treslin by cyclin-dependent kinase is essential for the onset of DNA replication. J. Cell Biol. 193, 995-1007.
28. Kumagai A, Shevchenko A, Dunphy WG. 2010. Treslin collaborates with TopBP1 in triggering the initiation ofDNAreplication. Cell 140, 349-359.
29. Leung CC, Glover JN. 2011. BRCT domains, easy as one, two, three. Cell Cycle 10, 2461-2470.
30. Li G, Sturgis EM. 2006. The role of human papillomavirus in squamous carcinoma of the head and neck. Curr. Oncol. Rep. 8, 130-139.
31. Liu K, et al. 2009. Regulation of p53 by TopBP1, a potential mechanism for p53 inactivation in cancer. Mol. Cell. Biol. 29, 2673-2693.
32. Liu K, Lin FT, Ruppert JM, Lin WC. 2003. Regulation of E2F1 by BRCT domain-containing protein TopBP1. Mol. Cell. Biol. 23, 3287-3304.
33. Liu K, Ling S, Lin WC. 2011. TopBP1 mediates mutant p53 gain of function through NF-Y and p63/p73. Mol. Cell. Biol. 31, 4464-4481.
34. Liu K, Luo Y, Lin FT, Lin WC. 2004. TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival. Genes Dev. 18, 673-686.
35. Makiniemi M, et al. 2001. BRCT domain-containing protein TopBP1 functions in DNA replication and damage response. J. Biol. Chem. 276, 30399-30406.
36. Masterson PJ, Stanley MA, Lewis AP, Romanos MA. 1998. A C-terminal helicase domain of the human papillomavirus E1 protein binds E2 and the DNA polymerase alpha-primase p68 subunit. J. Virol. 72, 7407-7419.
37. McPhillips MG, Oliveira JG, Spindler JE, Mitra R, McBride AA. 2006. Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J. Virol. 80, 9530-9543.
38. Melendy T, Sedman J, Stenlund A. 1995. Cellular factors required for papillomavirus DNA replication. J. Virol. 69, 7857-7867.
39. Meyers C, Laimins LA. 1994. In vitro systems for the study and propagation of human papillomaviruses. Curr. Top. Microbiol. Immunol. 186, 199-215.
40. Mohr IJ, et al. 1990. Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science 250, 1694-1699.
41. Moody CA, Laimins LA. 2010. Human papillomavirus oncoproteins, pathways to transformation. Nat. Rev. Cancer 10, 550-560.
42. Morishima K, et al. 2007. TopBP1 associates with NBS1 and is involved in homologous recombination repair. Biochem. Biophys. Res. Commun. 362, 872-879.
43. Oliveira JG, Colf LA, McBride AA. 2006. Variations in the association of papillomavirus E2 proteins with mitotic chromosomes. Proc. Natl. Acad. Sci. U. S. A. 103, 1047-1052.
44. Ozbun MA, Meyers C. 1998. Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification. Virology 248, 218-230.
45. Parish JL, Bean AM, Park RB, Androphy EJ. 2006. ChlR1 is required for loading papillomavirus E2 onto mitotic chromosomes and viral genome maintenance. Mol. Cell 24, 867-876.
46. Park P, et al. 1994. The cellular DNA polymerase alpha-primase is required for papillomavirusDNAreplication and associates with the viral E1 helicase. Proc. Natl. Acad. Sci. U. S. A. 91, 8700-8704.
47. Peng YC, Breiding DE, Sverdrup F, Richard J, Androphy EJ. 2000. AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins. J. Virol. 74, 5872-5879.
48. Piergiovanni G, Costanzo V. 2010. GEMC1 is a novel TopBP1-interacting protein involved in chromosomal DNA replication. Cell Cycle 9, 3662-3666.
49. Reini K, et al. 2004. TopBP1 localizes to centrosomes in mitosis and to chromosome cores in meiosis. Chromosoma 112, 323-330.
50. Romanczuk H, Villa LL, Schlegel R, Howley PM. 1991. The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of human papillomavirus types 16 and 18. J. Virol. 65, 2739-2744.
51. Ruesch M, Stubenrauch F, Laimins L. 1998. Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin 10. J. Virol. 72, 5016-5024.
52. Sakai H, Yasugi T, Benson JD, Dowhanick JJ, Howley PM. 1996. Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions. J. Virol. 70, 1602-1611.
53. Schiller JT, Castellsague X, Villa LL, Hildesheim A. 2008. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine 26(Suppl 10), K53-K61.
54. Schweiger MR, You J, Howley PM. 2006. Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function. J. Virol. 80, 4276-4285.
55. Sedman J, Stenlund A. 1998. The papillomavirus E1 protein forms a DNA-dependent hexameric complex with ATPase and DNA helicase activities. J. Virol. 72, 6893-6897.
56. Smith JA, et al. 2010. Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc. Natl. Acad. Sci. U. S. A. 107, 3752-3757.
57. Steele BK, Meyers C, Ozbun MA. 2002. Variable expression of some "housekeeping" genes during human keratinocyte differentiation. Anal. Biochem. 307, 341-347.
58. Tanaka S, et al. 2007. CDK-dependent phosphorylation of Sld2 and Sld3 initiates DNA replication in budding yeast. Nature 445, 328-332.
59. Taylor ER, Morgan IM. 2003. A novel technique with enhanced detection and quantitation of HPV-16 E1- and E2-mediated DNA replication. Virology 315, 103-109.
60. Thierry F, Howley PM. 1991. Functional analysis of E2-mediated repression of the HPV18 P105 promoter. New Biol. 3, 90-100.
61. Ustav M, Stenlund A. 1991. Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J. 10, 449-457.
62. Vance KW, Campo MS, Morgan IM. 2001. A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein. J. Virol. 75, 2829-2838.
63. Wang X, Naidu SR, Sverdrup F, Androphy EJ. 2009. Tax1BP1 interacts with papillomavirus E2 and regulates E2-dependent transcription and stability. J. Virol. 83, 2274-2284.
64. White PW, et al. 2003. Inhibition of human papillomavirus DNA replication by small molecule antagonists of the E1-E2 protein interaction. J. Biol. Chem. 278, 26765-26772.
65. Yoo HY, Kumagai A, Shevchenko A, Dunphy WG. 2007. Ataxiatelangiectasia mutated (ATM)-dependent activation of ATR occurs through phosphorylation of TopBP1 by ATM. J. Biol. Chem. 282, 17501-17506.
66. Yoo HY, Kumagai A, Shevchenko A, Dunphy WG. 2009. The Mre11-Rad50-Nbs1 complex mediates activation of TopBP1 by ATM. Mol. Biol. Cell 20, 2351-2360.
67. You J, Croyle JL, Nishimura A, Ozato K, Howley PM. 2004. Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117, 349-360.
68. Zegerman P, Diffley JF. 2007. Phosphorylation of Sld2 and Sld3 by cyclin-dependent kinases promotes DNA replication in budding yeast. Nature 445, 281-285.
69. zur Hausen H. 2009. Papillomaviruses in the causation of human cancers, a brief historical account. Virology 384, 260-265.